Published: August 6th 2024 | Updated: August 20th 2024
In This Issue: Total Pharmacy August 2024
Published: July 8th 2024 | Updated: July 10th 2024
SGLT2i, GLP-1RA Combination Therapy Offers Robust Protection Against Cardiovascular, Kidney Disease
Published: November 19th 2024 | Updated: December 25th 2024
Community Pharmacies Must Diversify Their Revenue Streams to Survive in Today’s Landscape
Published: December 12th 2024 | Updated: December 25th 2024
Gap in Biosimilar Knowledge Causes Barriers to Implementation | ASHP Midyear
Published: December 11th 2024 | Updated: December 25th 2024
SGLT2 Inhibitors Recommended for Treating CKD | ASHP Midyear
Published: December 11th 2024 | Updated: December 25th 2024
How Pharmacists Can Help Patients Manage MASLD | ASHP Midyear